XML 56 R43.htm IDEA: XBRL DOCUMENT
v3.20.2

Condensed Consolidating financial statements (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Condensed Consolidating Statements of Operations | Condensed Consolidating Statements of Operations
For the three months ended June 30, 2020 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Patient service revenues |  | $ | — |  |  | $ | 1,715,449 |  |  | $ | 1,120,072 |  |  | $ | (77,324 | ) |  | $ | 2,758,197 |
Other revenues |  | 211,996 |  |  | 163,738 |  |  | 30,625 |  |  | (284,577 | ) |  | 121,782 |
Total net revenues |  | 211,996 |  |  | 1,879,187 |  |  | 1,150,697 |  |  | (361,901 | ) |  | 2,879,979 |
Operating expenses |  | 250,311 |  |  | 1,663,321 |  |  | 918,328 |  |  | (361,901 | ) |  | 2,470,059 |
Operating (loss) income |  | (38,315 | ) |  | 215,866 |  |  | 232,369 |  |  | — |  |  | 409,920 |
Debt expense |  | (79,578 | ) |  | (52,604 | ) |  | (11,199 | ) |  | 62,000 |  |  | (81,381 | )
Other income, net |  | 59,980 |  |  | 658 |  |  | 10,907 |  |  | (62,000 | ) |  | 9,545 |
Income tax (benefit) expense |  | (14,449 | ) |  | 81,644 |  |  | 16,017 |  |  | — |  |  | 83,212 |
Equity earnings in subsidiaries |  | 245,066 |  |  | 159,325 |  |  | — |  |  | (404,391 | ) |  | — |
Net income from continuing operations |  | 201,602 |  |  | 241,601 |  |  | 216,060 |  |  | (404,391 | ) |  | 254,872 |
Net income from discontinued operations, net of tax |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Net income |  | 201,602 |  |  | 241,601 |  |  | 216,060 |  |  | (404,391 | ) |  | 254,872 |
Less: Net income attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | (53,270 | ) |  | (53,270 | )
Net income attributable to DaVita Inc. |  | $ | 201,602 |  |  | $ | 241,601 |  |  | $ | 216,060 |  |  | $ | (457,661 | ) |  | $ | 201,602 |
For the three months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Patient service revenues |  | $ | — |  |  | $ | 1,702,387 |  |  | $ | 1,085,912 |  |  | $ | (64,483 | ) |  | $ | 2,723,816 |
Other revenues |  | 207,299 |  |  | 150,985 |  |  | 39,395 |  |  | (278,790 | ) |  | 118,889 |
Total net revenues |  | 207,299 |  |  | 1,853,372 |  |  | 1,125,307 |  |  | (343,273 | ) |  | 2,842,705 |
Operating expenses and charges |  | 160,464 |  |  | 1,648,270 |  |  | 915,358 |  |  | (343,273 | ) |  | 2,380,819 |
Operating income |  | 46,835 |  |  | 205,102 |  |  | 209,949 |  |  | — |  |  | 461,886 |
Debt expense |  | (144,896 | ) |  | (50,925 | ) |  | (13,052 | ) |  | 65,047 |  |  | (143,826 | )
Other income, net |  | 102,059 |  |  | 690 |  |  | 10,982 |  |  | (108,088 | ) |  | 5,643 |
Income tax expense |  | 627 |  |  | 59,097 |  |  | 16,214 |  |  | — |  |  | 75,938 |
Equity earnings in subsidiaries |  | 270,180 |  |  | 139,681 |  |  | — |  |  | (409,861 | ) |  | — |
Net income from continuing operations |  | 273,551 |  |  | 235,451 |  |  | 191,665 |  |  | (452,902 | ) |  | 247,765 |
Net income from discontinued operations, net of tax |  | — |  |  | — |  |  | 36,351 |  |  | 43,041 |  |  | 79,392 |
Net income |  | 273,551 |  |  | 235,451 |  |  | 228,016 |  |  | (409,861 | ) |  | 327,157 |
Less: Net income attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | (53,606 | ) |  | (53,606 | )
Net income attributable to DaVita Inc. |  | $ | 273,551 |  |  | $ | 235,451 |  |  | $ | 228,016 |  |  | $ | (463,467 | ) |  | $ | 273,551 |
For the six months ended June 30, 2020 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non-Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net patient service revenues |  | $ | — |  |  | $ | 3,445,189 |  |  | $ | 2,170,949 |  |  | $ | (144,660 | ) |  | $ | 5,471,478 |
Other revenues |  | 409,279 |  |  | 320,598 |  |  | 72,053 |  |  | (552,192 | ) |  | 249,738 |
Total net revenues |  | 409,279 |  |  | 3,765,787 |  |  | 2,243,002 |  |  | (696,852 | ) |  | 5,721,216 |
Operating expenses |  | 404,962 |  |  | 3,304,142 |  |  | 1,833,668 |  |  | (696,852 | ) |  | 4,845,920 |
Operating income |  | 4,317 |  |  | 461,645 |  |  | 409,334 |  |  | — |  |  | 875,296 |
Debt expense |  | (170,940 | ) |  | (111,697 | ) |  | (22,536 | ) |  | 132,241 |  |  | (172,932 | )
Other income, net |  | 122,433 |  |  | 1,463 |  |  | 13,540 |  |  | (132,241 | ) |  | 5,195 |
Income tax (benefit) expense |  | (11,025 | ) |  | 162,619 |  |  | 23,178 |  |  | — |  |  | 174,772 |
Equity earnings in subsidiaries |  | 474,360 |  |  | 258,120 |  |  | — |  |  | (732,480 | ) |  | — |
Net income from continuing operations |  | 441,195 |  |  | 446,912 |  |  | 377,160 |  |  | (732,480 | ) |  | 532,787 |
Net income from discontinued operations, net of tax |  | — |  |  | — |  |  | 9,980 |  |  | — |  |  | 9,980 |
Net income |  | 441,195 |  |  | 446,912 |  |  | 387,140 |  |  | (732,480 | ) |  | 542,767 |
Less: Net income attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | (101,572 | ) |  | (101,572 | )
Net income attributable to DaVita Inc. |  | $ | 441,195 |  |  | $ | 446,912 |  |  | $ | 387,140 |  |  | $ | (834,052 | ) |  | $ | 441,195 |
For the six months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non-Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net patient service revenues |  | $ | — |  |  | $ | 3,408,980 |  |  | $ | 2,072,285 |  |  | $ | (127,760 | ) |  | $ | 5,353,505 |
Other revenues |  | 396,135 |  |  | 297,102 |  |  | 74,304 |  |  | (535,229 | ) |  | 232,312 |
Total net revenues |  | 396,135 |  |  | 3,706,082 |  |  | 2,146,589 |  |  | (662,989 | ) |  | 5,585,817 |
Operating expenses |  | 304,123 |  |  | 3,282,555 |  |  | 1,859,735 |  |  | (662,989 | ) |  | 4,783,424 |
Operating income |  | 92,012 |  |  | 423,527 |  |  | 286,854 |  |  | — |  |  | 802,393 |
Debt expense |  | (278,491 | ) |  | (101,575 | ) |  | (25,601 | ) |  | 130,322 |  |  | (275,345 | )
Other income, net |  | 212,257 |  |  | 1,338 |  |  | 22,042 |  |  | (223,054 | ) |  | 12,583 |
Income tax expense |  | 7,653 |  |  | 103,124 |  |  | 21,907 |  |  | — |  |  | 132,684 |
Equity earnings in subsidiaries |  | 404,715 |  |  | 204,056 |  |  | — |  |  | (608,771 | ) |  | — |
Net income from continuing operations |  | 422,840 |  |  | 424,222 |  |  | 261,388 |  |  | (701,503 | ) |  | 406,947 |
Net income from discontinued operations, net of tax |  | — |  |  | — |  |  | 16,965 |  |  | 92,732 |  |  | 109,697 |
Net income |  | 422,840 |  |  | 424,222 |  |  | 278,353 |  |  | (608,771 | ) |  | 516,644 |
Less: Net income attributable to noncontrolling interests |  | — |  |  | — |  |  | — |  |  | (93,804 | ) |  | (93,804 | )
Net income attributable to DaVita Inc. |  | $ | 422,840 |  |  | $ | 424,222 |  |  | $ | 278,353 |  |  | $ | (702,575 | ) |  | $ | 422,840 |
Condensed Consolidating Statements of Comprehensive Income | Condensed Consolidating Statements of Comprehensive Income
For the three months ended June 30, 2020 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net income |  | $ | 201,602 |  |  | $ | 241,601 |  |  | $ | 216,060 |  |  | $ | (404,391 | ) |  | $ | 254,872 |
Other comprehensive (loss) income |  | (201 | ) |  | — |  |  | 5,619 |  |  | — |  |  | 5,418 |
Total comprehensive income |  | 201,401 |  |  | 241,601 |  |  | 221,679 |  |  | (404,391 | ) |  | 260,290 |
Less: Comprehensive income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (53,270 | ) |  | (53,270 | )
Comprehensive income attributable to DaVita Inc. |  | $ | 201,401 |  |  | $ | 241,601 |  |  | $ | 221,679 |  |  | $ | (457,661 | ) |  | $ | 207,020 |
For the three months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net income |  | $ | 273,551 |  |  | $ | 235,451 |  |  | $ | 228,016 |  |  | $ | (409,861 | ) |  | $ | 327,157 |
Other comprehensive income |  | 1,575 |  |  | — |  |  | 12,365 |  |  | — |  |  | 13,940 |
Total comprehensive income |  | 275,126 |  |  | 235,451 |  |  | 240,381 |  |  | (409,861 | ) |  | 341,097 |
Less: Comprehensive income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (53,606 | ) |  | (53,606 | )
Comprehensive income attributable to DaVita Inc. |  | $ | 275,126 |  |  | $ | 235,451 |  |  | $ | 240,381 |  |  | $ | (463,467 | ) |  | $ | 287,491 |
For the six months ended June 30, 2020 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non-Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net income |  | $ | 441,195 |  |  | $ | 446,912 |  |  | $ | 387,140 |  |  | $ | (732,480 | ) |  | $ | 542,767 |
Other comprehensive loss |  | (11,596 | ) |  | — |  |  | (76,013 | ) |  | — |  |  | (87,609 | )
Total comprehensive income |  | 429,599 |  |  | 446,912 |  |  | 311,127 |  |  | (732,480 | ) |  | 455,158 |
Less: Comprehensive income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (101,572 | ) |  | (101,572 | )
Comprehensive income attributable to DaVita Inc. |  | $ | 429,599 |  |  | $ | 446,912 |  |  | $ | 311,127 |  |  | $ | (834,052 | ) |  | $ | 353,586 |
For the six months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non-Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Net income |  | $ | 422,840 |  |  | $ | 424,222 |  |  | $ | 278,353 |  |  | $ | (608,771 | ) |  | $ | 516,644 |
Other comprehensive income (loss) |  | 2,601 |  |  | — |  |  | (1,288 | ) |  | — |  |  | 1,313 |
Total comprehensive income |  | 425,441 |  |  | 424,222 |  |  | 277,065 |  |  | (608,771 | ) |  | 517,957 |
Less: Comprehensive income attributable to noncontrolling interest |  | — |  |  | — |  |  | — |  |  | (93,804 | ) |  | (93,804 | )
Comprehensive income attributable to DaVita Inc. |  | $ | 425,441 |  |  | $ | 424,222 |  |  | $ | 277,065 |  |  | $ | (702,575 | ) |  | $ | 424,153 |
Condensed Consolidating Balance Sheets | Condensed Consolidating Balance Sheets
As of June 30, 2020 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Cash and cash equivalents |  | $ | 2,719,413 |  |  | $ | 247 |  |  | $ | 209,250 |  |  | $ | — |  |  | $ | 2,928,910 |
Restricted cash and equivalents |  | 14,543 |  |  | — |  |  | 92,266 |  |  | — |  |  | 106,809 |
Accounts receivable, net |  | — |  |  | 1,170,426 |  |  | 601,833 |  |  | — |  |  | 1,772,259 |
Other current assets |  | 343,732 |  |  | 515,207 |  |  | 122,656 |  |  | (9,743 | ) |  | 971,852 |
Total current assets |  | 3,077,688 |  |  | 1,685,880 |  |  | 1,026,005 |  |  | (9,743 | ) |  | 5,779,830 |
Property and equipment, net |  | 568,053 |  |  | 1,550,132 |  |  | 1,307,385 |  |  | (7,652 | ) |  | 3,417,918 |
Operating lease right-of-use assets |  | 105,783 |  |  | 1,620,214 |  |  | 1,118,064 |  |  | (17,441 | ) |  | 2,826,620 |
Intangible assets, net |  | 317 |  |  | 26,004 |  |  | 87,058 |  |  | — |  |  | 113,379 |
Investments in and advances to affiliates, net |  | 11,216,535 |  |  | 8,467,107 |  |  | 3,203,408 |  |  | (22,887,050 | ) |  | — |
Other long-term assets and investments |  | 78,135 |  |  | 130,986 |  |  | 189,356 |  |  | (21,739 | ) |  | 376,738 |
Goodwill |  | — |  |  | 4,812,208 |  |  | 1,978,398 |  |  | — |  |  | 6,790,606 |
Total assets |  | $ | 15,046,511 |  |  | $ | 18,292,531 |  |  | $ | 8,909,674 |  |  | $ | (22,943,625 | ) |  | $ | 19,305,091 |
Current liabilities |  | $ | 2,254,858 |  |  | $ | 1,345,482 |  |  | $ | 670,742 |  |  | $ | 3,481 |  |  | $ | 4,274,563 |
Intercompany liabilities, net |  | 2,118,906 |  |  | 3,203,408 |  |  | 2,645,387 |  |  | (7,967,701 | ) |  | — |
Long-term operating leases liabilities |  | 131,709 |  |  | 1,530,117 |  |  | 1,064,328 |  |  | (16,585 | ) |  | 2,709,569 |
Long-term debt and other long-term liabilities |  | 7,671,918 |  |  | 798,494 |  |  | 318,264 |  |  | (43,471 | ) |  | 8,745,205 |
Noncontrolling interests subject to put provisions |  | 715,205 |  |  | — |  |  | — |  |  | 526,732 |  |  | 1,241,937 |
Total DaVita Inc. shareholders' equity |  | 2,153,915 |  |  | 11,415,030 |  |  | 3,504,319 |  |  | (14,919,349 | ) |  | 2,153,915 |
Noncontrolling interests not subject to put provisions |  | — |  |  | — |  |  | 706,634 |  |  | (526,732 | ) |  | 179,902 |
Total equity |  | 2,153,915 |  |  | 11,415,030 |  |  | 4,210,953 |  |  | (15,446,081 | ) |  | 2,333,817 |
Total liabilities and equity |  | $ | 15,046,511 |  |  | $ | 18,292,531 |  |  | $ | 8,909,674 |  |  | $ | (22,943,625 | ) |  | $ | 19,305,091 |
As of December 31, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Cash and cash equivalents |  | $ | 758,241 |  |  | $ | 532 |  |  | $ | 343,599 |  |  | $ | — |  |  | $ | 1,102,372 |
Restricted cash and equivalents |  | 14,499 |  |  | — |  |  | 91,847 |  |  | — |  |  | 106,346 |
Accounts receivable, net |  | — |  |  | 1,189,301 |  |  | 606,297 |  |  | — |  |  | 1,795,598 |
Other current assets |  | 76,787 |  |  | 548,553 |  |  | 102,410 |  |  | (41,896 | ) |  | 685,854 |
Total current assets |  | 849,527 |  |  | 1,738,386 |  |  | 1,144,153 |  |  | (41,896 | ) |  | 3,690,170 |
Property and equipment, net |  | 543,932 |  |  | 1,589,417 |  |  | 1,344,543 |  |  | (4,508 | ) |  | 3,473,384 |
Operating lease right-of-use assets |  | 109,415 |  |  | 1,656,145 |  |  | 1,084,552 |  |  | (20,065 | ) |  | 2,830,047 |
Intangible assets, net |  | 362 |  |  | 31,569 |  |  | 103,753 |  |  | — |  |  | 135,684 |
Investments in and advances to affiliates, net |  | 10,813,991 |  |  | 7,611,402 |  |  | 3,051,208 |  |  | (21,476,601 | ) |  | — |
Other long-term assets and investments |  | 102,779 |  |  | 133,698 |  |  | 176,315 |  |  | (18,318 | ) |  | 394,474 |
Goodwill |  | — |  |  | 4,812,972 |  |  | 1,974,663 |  |  | — |  |  | 6,787,635 |
Total assets |  | $ | 12,420,006 |  |  | $ | 17,573,589 |  |  | $ | 8,879,187 |  |  | $ | (21,561,388 | ) |  | $ | 17,311,394 |
Current liabilities |  | $ | 379,286 |  |  | $ | 1,327,378 |  |  | $ | 666,470 |  |  | $ | (1,036 | ) |  | $ | 2,372,098 |
Intercompany payables |  | 1,381,863 |  |  | 3,051,208 |  |  | 2,615,151 |  |  | (7,048,222 | ) |  | — |
Long-term operating lease liabilities |  | 136,123 |  |  | 1,567,776 |  |  | 1,039,145 |  |  | (19,244 | ) |  | 2,723,800 |
Long-term debt and other long-term liabilities |  | 7,741,725 |  |  | 674,558 |  |  | 364,102 |  |  | (64,507 | ) |  | 8,715,878 |
Noncontrolling interests subject to put provisions |  | 647,600 |  |  | — |  |  | — |  |  | 532,776 |  |  | 1,180,376 |
Total DaVita Inc. shareholders' equity |  | 2,133,409 |  |  | 10,952,669 |  |  | 3,475,710 |  |  | (14,428,379 | ) |  | 2,133,409 |
Noncontrolling interests not subject to put provisions |  | — |  |  | — |  |  | 718,609 |  |  | (532,776 | ) |  | 185,833 |
Total equity |  | 2,133,409 |  |  | 10,952,669 |  |  | 4,194,319 |  |  | (14,961,155 | ) |  | 2,319,242 |
Total liabilities and equity |  | $ | 12,420,006 |  |  | $ | 17,573,589 |  |  | $ | 8,879,187 |  |  | $ | (21,561,388 | ) |  | $ | 17,311,394 |
Condensed Consolidating Statements of Cash Flows | Condensed Consolidating Statements of Cash Flows
For the six months ended June 30, 2020 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Cash flows provided by operating activities: |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 441,195 |  |  | $ | 446,912 |  |  | $ | 387,140 |  |  | $ | (732,480 | ) |  | $ | 542,767 |
Changes in operating assets and liabilities and non-cash items included in net income |  | (357,763 | ) |  | 87,552 |  |  | 6,467 |  |  | 732,480 |  |  | 468,736 |
Net cash provided by operating activities |  | 83,432 |  |  | 534,464 |  |  | 393,607 |  |  | — |  |  | 1,011,503 |
Cash flows used in investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additions of property and equipment |  | (89,785 | ) |  | (93,331 | ) |  | (108,551 | ) |  | — |  |  | (291,667 | )
Acquisitions |  | — |  |  | (984 | ) |  | (43,283 | ) |  | — |  |  | (44,267 | )
Proceeds from asset and business sales |  | 2 |  |  | 2,991 |  |  | 67,622 |  |  | — |  |  | 70,615 |
(Purchases) proceeds from investment sales and other items, net |  | (134,674 | ) |  | 661 |  |  | (7,807 | ) |  | — |  |  | (141,820 | )
Net cash used in investing activities |  | (224,457 | ) |  | (90,663 | ) |  | (92,019 | ) |  | — |  |  | (407,139 | )
Cash flows provided by (used in) financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt and related financing costs, net |  | 1,694,037 |  |  | (5,468 | ) |  | (20,339 | ) |  | — |  |  | 1,668,230 |
Intercompany borrowings (payments) |  | 738,213 |  |  | (439,037 | ) |  | (299,176 | ) |  | — |  |  | — |
Other items |  | (330,009 | ) |  | 419 |  |  | (99,067 | ) |  | — |  |  | (428,657 | )
Net cash provided by (used in) financing activities |  | 2,102,241 |  |  | (444,086 | ) |  | (418,582 | ) |  | — |  |  | 1,239,573 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | — |  |  | — |  |  | (16,936 | ) |  | — |  |  | (16,936 | )
Net increase (decrease) in cash, cash equivalents and restricted cash |  | 1,961,216 |  |  | (285 | ) |  | (133,930 | ) |  | — |  |  | 1,827,001 |
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year |  | 772,740 |  |  | 532 |  |  | 435,446 |  |  | — |  |  | 1,208,718 |
Cash, cash equivalents and restricted cash of continuing operations at end of the period |  | $ | 2,733,956 |  |  | $ | 247 |  |  | $ | 301,516 |  |  | $ | — |  |  | $ | 3,035,719 |
For the six months ended June 30, 2019 |  | DaVita Inc. |  | Guarantor subsidiaries |  | Non- Guarantor subsidiaries |  | Consolidating adjustments |  | Consolidated total
Cash flows provided by operating activities: |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 422,840 |  |  | $ | 424,222 |  |  | $ | 278,353 |  |  | $ | (608,771 | ) |  | $ | 516,644 |
Changes in operating assets and liabilities and non-cash items included in net income |  | (292,988 | ) |  | (198,192 | ) |  | 116,880 |  |  | 608,771 |  |  | 234,471 |
Net cash provided by operating activities |  | 129,852 |  |  | 226,030 |  |  | 395,233 |  |  | — |  |  | 751,115 |
Cash flows provided by (used in) investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additions of property and equipment |  | (63,037 | ) |  | (148,050 | ) |  | (162,831 | ) |  | — |  |  | (373,918 | )
Acquisitions |  | — |  |  | (8,974 | ) |  | (56,996 | ) |  | — |  |  | (65,970 | )
Proceeds from asset and business sales |  | 3,824,509 |  |  | 1,194 |  |  | 25,678 |  |  | — |  |  | 3,851,381 |
Proceeds (purchases) from investment sales and other items, net |  | 729 |  |  | (6,492 | ) |  | (3,038 | ) |  | — |  |  | (8,801 | )
Net cash provided by (used in) investing activities |  | 3,762,201 |  |  | (162,322 | ) |  | (197,187 | ) |  | — |  |  | 3,402,692 |
Cash flows provided by financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt and related financing costs, net |  | (1,152,510 | ) |  | (6,611 | ) |  | (4,988 | ) |  | — |  |  | (1,164,109 | )
Intercompany borrowings (payments) |  | 656,704 |  |  | (58,208 | ) |  | (598,496 | ) |  | — |  |  | — |
Other items |  | (82,011 | ) |  | 86 |  |  | (64,519 | ) |  | — |  |  | (146,444 | )
Net cash used in financing activities |  | (577,817 | ) |  | (64,733 | ) |  | (668,003 | ) |  | — |  |  | (1,310,553 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash |  | — |  |  | — |  |  | (77 | ) |  | — |  |  | (77 | )
Net increase (decrease) in cash, cash equivalents and restricted cash |  | 3,314,236 |  |  | (1,025 | ) |  | (470,034 | ) |  | — |  |  | 2,843,177 |
Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations |  | — |  |  | — |  |  | (423,813 | ) |  | — |  |  | (423,813 | )
Net increase (decrease) in cash, cash equivalents and restricted cash from continuing operations |  | 3,314,236 |  |  | (1,025 | ) |  | (46,221 | ) |  | — |  |  | 3,266,990 |
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year |  | 61,658 |  |  | 13,280 |  |  | 340,482 |  |  | — |  |  | 415,420 |
Cash, cash equivalents and restricted cash of continuing operations at end of the period |  | $ | 3,375,894 |  |  | $ | 12,255 |  |  | $ | 294,261 |  |  | $ | — |  |  | $ | 3,682,410 |

X
- Definition Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_CondensedStatementOfComprehensiveIncomeTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph i -Subsection 10 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration